Tag: NET cancer

Los-Angeles-Conference-June-2016Flyer_2

Los Angeles Neuroendocrine Tumor Patient Education Conference 2016

June 14, 2016

Join neuroendocrine tumor (NET) patients and family members, NET cancer expert physicians, and members of the healthcare community on Saturday, June 25, 2016 for a free, one-day conference at Cedars-Sinai Medical Center in Los Angeles.  The conference…

READ MORE
Charlotte NC collage_2

2014 National NET Cancer Patient Conference — Registration Now Open

January 30, 2014

Carcinoid and NET (neuroendocrine tumor) cancer patients, caregivers and family members, as well as physicians and other health professionals, have a unique opportunity to learn more about NET cancer, including the latest information about diagnosis…

READ MORE
Hands and smartphone

Mobile Survey for Carcinoid Syndrome Community

January 16, 2014

Carcinoid syndrome patients, caregivers, and advocates in the carcinoid syndrome community are invited to participate in an exclusive mobile survey being conducted by WEGO Health via Truvio.

WEGO Health is an organization committed to empowering…

READ MORE
Hope, in sand

Remembering Dr. Martin Luther King and Sharing the Carcinoid Cancer Foundation’s Dream

August 28, 2013

Fifty years ago today, August 28, 1963, the Rev. Dr. Martin Luther King gave his historic speech, “I Have a Dream.”  That enormously powerful speech, http://youtu.be/smEqnnklfYs, still resonates with people decades later. As we listened to Dr.…

READ MORE
Society of Nuclear Medicine and Molecular Imaging, Patient Program, June 9, 2013, Vancouver, Canada

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE
Dr. Matthew Kulke is the moderator of the new OncLive TV series on Neuroendocrine Tumors

New OncLive TV Series Focuses on Neuroendocrine Tumors

March 24, 2013

Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …

READ MORE
35 United States Governors issued proclamations and letters of support for NET Cancer Day 2012

Happy New Year from the Carcinoid Cancer Foundation

December 28, 2012

As 2012 draws to a close, the Carcinoid Cancer Foundation would like to thank each of you for your support.  This year has been especially exciting because of our work on the Worldwide NET Cancer Awareness Day Alliance, with Grace Goldstein, CCF’s Chief…

READ MORE
"Sunny" Susan Anderson Selected as Winner of 2012 Warner Advocacy Award

“Sunny Susan” Anderson Wins 2012 Warner Advocacy Award

December 11, 2012

When “Sunny Susan” Anderson began her search on the Internet in 1995 for information about carcinoid cancer little did she realize that she would later create the first carcinoid patient website and become an extraordinary advocate for others seeking…

READ MORE
Eric Liu, MD, Vanderbilt University and patient

Neuroendocrine Tumor Webinar Just Opened to Patients and the Public

August 21, 2012

Just opened to the patient community and the public, with limited space available, is a free live webinar featuring carcinoid and NET cancer specialist Dr. Eric Liu, Director of the Neuroendocrine Center at Vanderbilt University Medical Center in Nashville,…

READ MORE
Lexicon Pharmaceuticals headquarters

Lexicon Pharmaceuticals Granted Orphan Drug Designation by FDA for Carcinoid Syndrome Treatment

April 2, 2012

Lexicon Pharmaceuticals, Inc. has been granted Orphan Drug Designation for telotristat etiprate (LX1032) by the U.S. Food and Drug Administration (FDA).  LX1032 is used to treat carcinoid syndrome, a chronic condition caused by neuroendocrine …

READ MORE